[ORIENTATIONAL CRITERIA IN RADIOTHERAPY OF PRIMARY TUMORS OF THE OVARY].
D000230:Adenocarcinoma; D000970:Antineoplastic Agents; D002859:Chromium Isotopes; D003036:Cobalt Isotopes; D003536:Cystadenocarcinoma; D003537:Cystadenoma; D018291:Cystadenoma, Mucinous; D018292:Cystadenoma, Papillary; D004407:Dysgerminoma; D005260:Female; D017979:Gold Colloid; D006048:Gold Colloid, Radioactive; D006106:Granulosa Cell Tumor; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D010051:Ovarian Neoplasms; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D011883:Radium; D013514:Surgical Procedures, Operative; D015020:Yttrium Isotopes
D000970:Antineoplastic Agents; D002859:Chromium Isotopes; D003036:Cobalt Isotopes; D017979:Gold Colloid; D006048:Gold Colloid, Radioactive; D015020:Yttrium Isotopes; D011883:Radium
ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CHROMIUM ISOTOPES; COBALT ISOTOPES; CYSTADENOCARCINOMA; CYSTADENOMA, MUCINOUS; CYSTADENOMA, PAPILLARY; DISGERMINOMA; GOLD COLLOID, RADIOACTIVE; GRANULOSA CELL TUMOR; NEOPLASM RADIOTHERAPY; OVARIAN NEOPLASMS; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY DOSAGE; RADIUM; SURGERY, OPERATIVE; YTTRIUM ISOTOPES
CRITERI DI ORIENTAMENTO NELLA RADIOTERAPIA DEI TUMORI PRIMITIVI DELL'OVAIO.